The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Adulterants in illicit drugs: a review of empirical evidence
Abstract
Widespread public perception is that illicit drugs contain substances that are a serious risk to health, even though adulterants are often not considered in clinical or forensic toxicology. This review attempts to present an evidence‐based overview of adulterants in illicit drugs, and their associated toxicity. Adulterants are deliberately added to increase bulk, enhance or mimic a pharmacological effect, or to facilitate drug delivery. Those present unintentionally are as a result of poor manufacturing techniques. From the reports gathered, adulterants are predominantly substances which are readily available, commonly being caffeine, procaine, paracetamol, and sugars. These are likely to have minimal impact on users' health at low dosages. Other adulterants, particularly in injectable drugs, have the potential to cause serious health issues, but the quantities reported, such as strychnine in heroin, are not life‐threatening. The most commonly identified bacterial contaminants identified are Bacillus and Clostridium species. When death or serious illness due to adulteration occurs, circulation of information is particularly vital, such as in the USA regarding heroin and cocaine adulterated with fentanyl, and in Scotland recently regarding anthrax contaminated heroin. The complex interactions of supply, demand, and control of illicit drugs have a tangible impact on their adulteration. Continuing vigilance and the circulation of information is, therefore, desirable as a public health issue. As part of that strategy, analyses performed for adulterants needs to be encouraged, which are considerably limited in number and scope at the moment. Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
United Nations Office on Drugs and Crime (2010) · World drug report · doi:10.18356/079beef9-en · Cited by 987
Taking Care of Business—The Heroin User's Life on the Street
Preble, E., & Casey, J. J. (1969) · International Journal of the Addictions · doi:10.3109/10826086909061998 · Cited by 692
Injectional anthrax in a heroin skin-popper
Ringertz, S. H., Høiby, E. A., Jensenius, M., Caugant, D. A., Myklebust, A. T., & Fossum, K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03133-0 · Cited by 413
Agranulocytosis After Consumption of Cocaine Adulterated With Levamisole
Zhu, N. Y., LeGatt, D. F., & Turner, A. R. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-4-200902170-00102 · Cited by 144
Outbreak of Necrotizing Fasciitis Due to Clostridium sordellii among Black-Tar Heroin Users
Kimura, A. C., Higa, J. I., Levin, R. M., Simpson, G., Vargas, Y., & Vugia, D. J. (2004) · Clinical Infectious Diseases · doi:10.1086/383471 · Cited by 141
Amphetamine Derivative Fatalities in South Australia-Is "Ecstasy" the Culprit?
Byard, R. W., Gilbert, J. D., James, R., & Lokan, R. J. (1998) · American Journal of Forensic Medicine & Pathology · doi:10.1097/00000433-199809000-00013 · Cited by 122
Aluminum in Tobacco and Cannabis and Smoking-Related Disease
Exley, C., Begum, A., Woolley, M. P., & Bloor, R. N. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.08.004 · Cited by 116
Chemical Analysis of Ecstasy Pills
Baggott, M. J., Heifets, B. D., Jones, R. T., Mendelson, J., Sferios, E., & Zehnder, J. (2000) · JAMA · doi:10.1001/jama.284.17.2190 · Cited by 116
Pharmacological content of tablets sold as “ecstasy”: Results from an online testing service
Tanner‐Smith, E. E. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.11.016 · Cited by 98
An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants
Brunt, T. M., Rigter, S., Hoek, J., Vogels, N., Dijk, P. V., & Niesink, R. J. M. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02532.x · Cited by 95
Sherlock, K., Wolff, K., Hay, A. W. M., & Conner, M. T. (1999) · Emergency Medicine Journal · doi:10.1136/emj.16.3.194 · Cited by 94
Coomber, R., & Maher, L. (2006) · Journal of Drug Issues · doi:10.1177/002204260603600310 · Cited by 92
McGUIGAN, C. C., Penrice, G., Gruer, L. D., Ahmed, S. F., GOLDBERG, D., Black, M., Salmon, J. E., & HOOD, J. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-11-971 · Cited by 90
Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia
Knowles, L., Buxton, J. A., Skuridina, N., Achebe, I., LeGatt, D. F., Fan, S., Zhu, N. Y., & Talbot, J. (2009) · Harm Reduction Journal · doi:10.1186/1477-7517-6-30 · Cited by 83
Lead Poisoning Due to Adulterated Marijuana
Busse, F., Omidi, L., Leichtle, A. B., Windgassen, M., Kluge, E., & Stümvoll, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0707784 · Cited by 71
MONITORING SYNTHETIC DRUG MARKETS, TRENDS, AND PUBLIC HEALTH
Spruit, I. P. (2001) · Substance Use & Misuse · doi:10.1081/ja-100000227 · Cited by 66
Three Fatalities Involving Phosphine Gas, Produced as a Result of Methamphetamine Manufacturing
Willers-Russo, L. (1999) · Journal of Forensic Sciences · doi:10.1520/jfs14525j · Cited by 61
A Descriptive Study of an Outbreak of Clenbuterol-Containing Heroin
Hoffman, R. S., Kirrane, B. M., & Marcus, S. M. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.04.026 · Cited by 60
The health and psycho-social consequences of ketamine use
Copeland, J., & Dillon, P. (2005) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2004.12.003 · Cited by 59
The contribution of impurities to the acute morbidity of illegal drug use
Shesser, R. F., Jotte, R. S., & Olshaker, J. (1991) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(91)90053-m · Cited by 53
Quality of heroin and heroin‐related deaths from 1987 to 1995 in Vienna, Austria
Risser, D., Uhl, A., Stichenwirth, M., Hönigschnabl, S., Hirz, W., Schneider, B., Stellwag-Carion, C., Klupp, N., Vycudilik, W., & Bauer, G. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9533758.x · Cited by 50
Necrotizing Fasciitis: Manifestations, Microbiology and Connection with Black Tar Heroin*
Dunbar, N. M., & Harruff, R. C. (2007) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2007.00452.x · Cited by 50
Bacillus cereus cellulitis from contaminated heroin
Dancer, S. J., McNAIR, D., FINN, P., & Kolsto, A.-B. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-3-278 · Cited by 49
Unusual strychnine poisoning and its treatment: report of eight cases.
O’Callaghan, W. G., Joyce, N. E., Counihan, H. E., Ward, M., Lavelle, P., & O'Brien, E. (1982) · BMJ · doi:10.1136/bmj.285.6340.478 · Cited by 46
Quality Control by Cocaine Users: Underdeveloped Harm Reduction Strategies
Decorte, T. (2001) · European Addiction Research · doi:10.1159/000050737 · Cited by 45
Risser, D., Uhl, A., Oberndorfer, F., Hönigschnabl, S., Stichenwirth, M., Hirz, R., & Sebald, D. (2007) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2007.00507.x · Cited by 36
Wound botulism in drug addicts in the United Kingdom
Mulleague, L., Bonner, S., Samuel, A., Nichols, P., Khan, M. I., Shaw, S., & Grüning, T. (2001) · Anaesthesia · doi:10.1046/j.1365-2044.2001.01833.x · Cited by 25
Phenacetin and cocaine in a body packer
Fucci, N. (2004) · Forensic Science International · doi:10.1016/j.forsciint.2003.12.012 · Cited by 15
Cited by
Public health and international drug policy
Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., Cepeda, J., Comfort, M., Goosby, E., Goulão, J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00619-x · Cited by 641
Shin, S. S., LaForge, K., Stack, E., Pope, J., Leichtling, G., Larsen, J. E., Leahy, J. M., Seaman, A., Hoover, D., Chisholm, L., et al. (2022) · Harm Reduction Journal · doi:10.1186/s12954-022-00659-9 · Cited by 25
Metadata
- Authors
- Cole, C., Jones, L., McVeigh, J., Kicman, A., Syed, Q., & Bellis, M.
- Venue
- Drug Testing and Analysis
- Publisher
- Wiley
- Published
- 2010-12-29
- Volume
- 3
- Issue
- 2
- Pages
- 89-96
- ISSN
- 1942-7603 (ISSN-L)
- 1942-7611
- OpenAlex
- W2136567229
- Cited by
- 281
- References
- 28
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.